+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Effects of low-dose continuous combined hormone replacement therapy on glucose homeostasis and markers of cardiovascular risk in women with type 2 diabetes



Effects of low-dose continuous combined hormone replacement therapy on glucose homeostasis and markers of cardiovascular risk in women with type 2 diabetes



Clinical Endocrinology 66(1): 27-34



Low-dose hormone replacement therapy (HRT) has attracted interest for the treatment of postmenopausal symptoms in diabetes because of concerns about increased risk of coronary heart disease (CHD) and stroke with conventional HRT containing conjugated equine oestrogens (CEEs) and medroxyprogesterone acetate (MPA). We assessed the effects on glucose homeostasis and cardiovascular risk factors of continuous oral 17beta oestradiol (1 mg) and norethisterone (0.5 mg) in postmenopausal women with type 2 diabetes. Double-blind, randomized placebo-controlled trial. Hyperinsulinaemic isoglycaemic clamp and cardiovascular risk factors were assessed before and after 3 months of treatment. Twenty-eight women completed the study. HRT decreased fasting glucose compared with placebo [-9.4% with HRT vs.+2.3% for placebo, 95% confidence interval (CI) -23.2 to -0.3] and total cholesterol (-13.7 vs.+1.0%, 95% CI -22.4 to -3.1%) No significant effect was seen on metabolic clearance rate of glucose, glycated haemoglobin (HbA1c), triglycerides, high density lipoprotein (HDL)-cholesterol or C-reactive protein (CRP). In women with type 2 diabetes, low-dose HRT decreased fasting glucose and total cholesterol without detectable adverse effects on glucose clearance, triglycerides and CRP as reported with conventional HRT.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 048910834

Download citation: RISBibTeXText

PMID: 17201798

DOI: 10.1111/j.1365-2265.2006.02679.x


Related references

A randomised double-blind placebo-controlled trial of the effects on bone metabolism of a low dose continuous combined hormone replacement therapy in women with type 2 diabetes. Diabetologia 45(Suppl. 2): A 89, 2002

A randomised double-blind placebo-controlled trial of a low dose continuous combined Hormone replacement therapy in women with type 2 diabetes. Diabetologia 44(Suppl. 1): A 47, 2001

Differential effects of raloxifene and continuous combined hormone replacement therapy on biochemical markers of cardiovascular risk: results from the Euralox 1 study. Climacteric 4(4): 320-331, 2001

Differential effects of raloxifene and continuous combined hormone replacement therapy on biochemical markers of cardiovascular risk: results from the Euralox 1 study. Climacteric 4(4): 320-331, 2001

Randomized trial of effect of transdermal continuous combined hormone replacement therapy on cardiovascular risk markers. British Journal of Haematology 124(6): 802-808, 2004

Effects of low-dose, continuous combined hormone replacement therapy on sleep in symptomatic postmenopausal women. Maturitas 50(2): 91-97, 2005

Effects of hormone replacement therapy on cardiovascular responses in postmenopausal women with and without type 2 diabetes. Maturitas 43(3): 157-164, 2002

Effects of hormone replacement therapy on glucose and lipid profiles and on cardiovascular risk parameters in postmenopausal women. Archives of Gynecology and Obstetrics 281(5): 857-864, 2010

The effects of hormone replacement therapy combined with vitamins C and E on antioxidants levels and lipid profiles in postmenopausal women with Type 2 diabetes. Clinica Chimica Acta; International Journal of Clinical Chemistry 344(1-2): 63-71, 2004

The effects of hormone replacement therapy combined with vitamins C and E on antioxidants levels and lipid profiles in postmenopausal women with Type 2 diabetes*1. Clinica Chimica Acta 344(1-2): 63-71, 2004

Continuous low-dose combined hormone replacement therapy and the risk of endometrial cancer. Gynecologic Oncology 64(3): 425-430, 1997

Metabolic, inflammatory and haemostatic effects of a low-dose continuous combined HRT in women with type 2 diabetes: potentially safer with respect to vascular risk?. Clinical Endocrinology 59(6): 682-689, 2003

Metabolic, Inflammatory, and Hemostatic Effects of a Low-Dose Continuous Combined HRT in Women With Type 2 Diabetes: Potentially Safer With Respect to Vascular Risk. Obstetric and Gynecologic Survey 59(7): 524-525, 2004

The effect of continuous combined HRT on glucose homeostasis and plasma lipids. A placebo-controlled study in postmenopausal women with type 2 diabetes. Maturitas 53(4): 430-438, 2006

Effect of hormone replacement therapy on cardiovascular risk factors in postmenopausal women with diabetes. Diabetes Obesity and Metabolism 6(1): 16-22, 2004